AstraZeneca Pharmaceuticals (Ireland) DAC (AstraZeneca)

Lobbying Organisation AstraZeneca Pharmaceuticals (Ireland) DAC

Date published 20 May, 2022

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Jan, 2022 to 30 Apr, 2022

Specific Details Briefing on AstraZeneca's Covid-19 treatments

Intended results Updating stakeholders on AstraZeneca's development and rollout of medicines to help prevent and treat COVID-19

Name of person primarily responsible for lobbying on this activity Colin O'Donnell

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (2-5)

Emails updating on AstraZeneca's Covid-19 treatments

Phone call (2-5)

Calls updating on AstraZeneca's Covid-19 treatments

Submission (2-5)

Submitted briefing paper on AstraZeneca's Covid-19 treatments

Meeting (2-5)

Met with stakeholders on AstraZeneca's Covid-19 treatments

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Deirdre Gillane Chief of Staff (Department of the Taoiseach)

Paraic Gallagher Special Adviser (Department of Health)

Susan Mitchell Special Adviser (Department of Health)

Micheál Martin An Taoiseach (Department of the Taoiseach)

Stephen Donnelly Minister (Department of Health)

Colm Burke TD (Dáil Éireann, the Oireachtas)